Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “To Determine the Bioequivalence Under Fasting Conditions”

Showing 14 of 0 results

Early research (Phase 1)Study completedNCT00652886
What this trial is testing

Bioavailability Study of Oxandrolone Tablets Under Fasting Conditions

Who this might be right for
To Determine the Bioequivalence Under Fasting Conditions
Par Pharmaceutical, Inc. 26
Early research (Phase 1)Study completedNCT01797926
What this trial is testing

Study to Determine the Bioequivalence of Two Fixed Dose Combination (FDC) Tablet Formulations of Amlodipine and Losartan FDC5/50 and FDC5/100 Under Fasting Conditions

Who this might be right for
Hypertension
GlaxoSmithKline 102
Post-approval studies (Phase 4)Study completedNCT02446483
What this trial is testing

A Bioequivalence Study of Idiazole 20mg DR Tabs and PARIET® 20 mg DR Tabs After a Single Oral Dose Administration Under Fasting Conditions in Healthy Adults

Who this might be right for
Gastrointestinal Diseases
GlaxoSmithKline 60
Early research (Phase 1)Study completedNCT05135793
What this trial is testing

Bioequivalence Study of Vonoprazan From Topoprazan 20 mg Tablets (Hikma Pharma, Egypt) Versus Takecab 20 mg Tablets (Takeda Pharmaceutical Co. Ltd., Japan)

Who this might be right for
Healthy
Genuine Research Center, Egypt 29
Early research (Phase 1)Study completedNCT04657744
What this trial is testing

Bioequivalence Study of Fingolimod From Sphingomod 0.5 mg Hard Gelatin Capsules (Hikma Pharma, Egypt) Versus Gilenya 0.5 mg Hard Capsules (Novartis Pharma AG, Basle, Switzerland).

Who this might be right for
Healthy
Genuine Research Center, Egypt 34
Early research (Phase 1)Study completedNCT02201316
What this trial is testing

A Pilot Study to Determine the Relative Bioavailability of Mosapride 5mg From Two Candidate Formulations of GR107719B Relative to One 5mg Tablet of Reference Mosapride Citrate (GASMOTIN™) in Healthy Adult Human Subjects Under Fasting Conditions

Who this might be right for
Gastritis
GlaxoSmithKline 18
Early research (Phase 1)Study completedNCT01380509
What this trial is testing

Bioavailability Study of Metronidazole Capsules Under Fasting Conditions

Who this might be right for
To Determine the Bioequivalence Study Under Fasting
Par Pharmaceutical, Inc. 28
Early research (Phase 1)Study completedNCT02502812
What this trial is testing

Bioequivalence Study of Clopidogrel 75 mg in Two Tablet Formulations Relative to Reference Tablet in Healthy Subjects

Who this might be right for
Cardiovascular Disease
GlaxoSmithKline 18
Early research (Phase 1)Study completedNCT00652665
What this trial is testing

Bioavailability Study of Leflunomide Tablets Under Fasting Conditions

Who this might be right for
To Determine the Bioequivalence Study Under Fasting
Par Pharmaceutical, Inc. 52
Early research (Phase 1)Study completedNCT02006589
What this trial is testing

Bioavailability Study of Candesartan Cilexetil 8mg Tablet Under Fasting Conditions

Who this might be right for
Hypertension
GlaxoSmithKline 16
Early research (Phase 1)Study completedNCT06326697
What this trial is testing

Bioequivalence of Azacitidine 300 mg Film-Coated Tablets in Adult Patients With Acute Myeloid Leukaemia (AML)

Who this might be right for
Acute Myeloid Leukaemia
Hikma Pharmaceuticals LLC 32
Early research (Phase 1)Study completedNCT03432273
What this trial is testing

Single-Dose Bioequivalence Study Comparing Two 2 mg Nicotine Lozenges

Who this might be right for
Smoking Cessation
Fertin Pharma A/S 42
Early research (Phase 1)WithdrawnNCT02980757
What this trial is testing

Bioequivalence Study of Gliclazide 120 mg Modified Release Tablets

Who this might be right for
Comparative Bioavailability
Disphar International B.V.
Early research (Phase 1)Study completedNCT02658422
What this trial is testing

Bioequivalence of GW483100 10 Milligram (mg) Tablets in Healthy Subjects Under Fasting Conditions

Who this might be right for
Respiratory DisordersAsthma and Rhinitis
GlaxoSmithKline 32

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation